Status:
COMPLETED
Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery
Lead Sponsor:
Claus Anders Bertelsen, PhD, MD
Conditions:
Pain, Postoperative
Pain, Abdominal
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the trial is to identify the "most simple non-inferior of three different methods", placebo, laparoscopic assisted transverse abdominal plane block (L-TAP) and ultrasound guided TAP blo...
Detailed Description
Introducing laparoscopy in colorectal surgery and optimizing the postoperative care using the standardized protocols of enhanced recovery after surgery (ERAS) have significantly improved patient outco...
Eligibility Criteria
Inclusion
- Patients planned to receive curative elective minimally invasive colon surgery for colon cancer or adenoma without a planned ostomy. Colon cancer or adenoma is defined by a distance of more than 15 cm from the anal verge to the distal limitation of the tumour or adenoma as measured by rigid sigmoidoscope. The following procedural codes are included:
- Laparoscopic ileocecal resection
- Laparoscopic right hemicolectomy
- Other laparoscopic resection of both small and large bowel
- Laparoscopic resection of transverse colon
- Laparoscopic left hemicolectomy
- Laparoscopic resection of sigmoid colon
- Other laparoscopic colon resection
- Having given informed written consent.
Exclusion
- Known allergy to local analgesics
- Known liver failure Class C according to the Child-Pugh Score
- Body weight of less than 40 kg
- History of being a chronic pain patient (weekly intake WHO step II or step III or adjuvant step I analgesic)
- Presence of concomitant painful conditions other than low back pain that could confound the subject's trial assessments or self-evaluation of the index pain, e.g., syndromes with widespread pain such as fibromyalgia
- Predictably non-compliant due to language barrier or psychiatric disease
- Patients rescheduled for open surgery, before the intervention has been administered
- Patients where the indication for surgery changes before the intervention has been administered
- Patients with known inflammatory bowel disease
- Patients who have previously undergone open major abdominal surgery defined by prior intraabdominal surgery with a midline or upper abdominal incision of more than 8 cm
- Incisional hernia
- Patients with a history of abdominal wall surgery including resection of the external oblique muscles, the internal oblique muscles, the transversus abdominis muscles, the rectus abdominis muscles or their fascial components
- Pregnancy (patients are screened using urine human chorionic gonadotropin upon admission if female and not postmenopausal).
Key Trial Info
Start Date :
January 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04311099
Start Date
January 14 2021
End Date
March 31 2024
Last Update
August 7 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Sydvestjysk Sygehus
Esbjerg, Denmark, 6700
2
Regionshospitalet Herning
Herning, Denmark, 7400
3
Copenhagen University Hospital - North Zealand
Hillerød, Denmark, 3400
4
Copenhagen University Hospital - Hvidovre
Hvidovre, Denmark, 2650